Keller, J
Gomez, R
Williams, G
Lembke, A
Lazzeroni, L http://orcid.org/0000-0002-1846-6920
Murphy, G M Jr
Schatzberg, A F
Article History
Received: 28 July 2015
Revised: 11 May 2016
Accepted: 7 June 2016
First Online: 16 August 2016
Competing interests
: Although there is not a conflict of interest, there may appear to be one with Dr Schatzberg. He has a significant interest in Corcept Therapeutics, which licensed the use patent for mifepristone in psychotic major depression. Some of the data presented here were part of a larger study examining the effectiveness of mifepristone in psychotic major depression. No data on mifepristone’s effectiveness are presented in the submitted report. Several authors have been named on a use patent related to the SNPs reported in this manuscript, including Alan Schatzberg, Greer Murphy and Jennifer Keller. Dr Greer Murphy has been a consultant for Brain Resource.